drugset / Trial / NCT00551824

Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children

NCT00551824

Unknown 10 enrolled Federal University of São Paulo
RandomizedCrossoverSingle-blindTreatment

Summary

This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal strictures. This is a crossover, controlled, clinical trial in which children with esophageal stricture will be randomized in two groups to receive either topical mitomycin or no additional treatment during standard esophageal dilation session.

Timeline

Start
2007-10
Primary completion
2008-12
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitomycin C Other / unclassified 0.4 mg/ml Topical

Indications